This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bjornsson, J. Articles by Henske, E. P. Search for Related Content PubMed PubMed Citation Articles by Bjornsson, J. Articles by Henske, E. P.

American Journal of Pathology, Vol 149, 1201-1208, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features

J Bjornsson, MP Short, DJ Kwiatkowski and EP Henske
Department of Pathology, Mayo Clinic, Rochester Minnesota, USA.

The tuberous sclerosis complex (TSC) is a multisystem autosomal dominant disorder characterized by seizures, mental retardation, and hamartomas. Patients with TSC have been reported to develop renal cell carcinomas (RCC) with increased frequency, an observation that is supported by the Eker rat model. To address the role of the tuberous sclerosis tumor suppressor genes in the pathogenesis of RCC, we studied six TSC-associated RCCs. Our findings suggest that some TSC-associated RCCs have clinical, pathological, or genetic features distinguishing them from sporadic RCC. Clinically, the TSC-associated tumors occurred at a younger age (mean, 36 years) than sporadic tumors and occurred primarily in women. Four of the six patients died of metastatic disease. Pathologically, five tumors displayed clear cell morphology. Of those five, two had high-grade spindle cell areas and one had granular cell histology in addition to the clear cell areas. A sixth tumor was anaplastic throughout. Four of the six tumors immunostained positively for a melanocyte-associated marker, HMB-45. HMB-45 positivity has been seen in two other TSC lesions: renal angiomyolipomas and pulmonary lymphangiomyomatosis. Five tumors were analyzed for loss of heterozygosity. Two had loss of heterozygosity on chromosome 9q34 and one had loss of heterozygosity on chromosome 16p13. We conclude that TSC-associated RCCs occur at an earlier age than sporadic RCCs, that some TSC-associated renal carcinomas have a different immunophenotype than sporadic RCCs, and that the TSC tumor suppressor genes may play a specific pathogenic role in these tumors.

This article has been cited by other articles:

				P. B. Crino, K. L. Nathanson, and E. P. Henske The Tuberous Sclerosis Complex. N. Engl. J. Med., September 28, 2006; 355(13): 1345 - 1356. [Full Text] [PDF]

				E. Lesma, V. Grande, S. Carelli, D. Brancaccio, M. P. Canevini, R. M. Alfano, G. Coggi, A. M. Di Giulio, and A. Gorio Isolation and Growth of Smooth Muscle-Like Cells Derived from Tuberous Sclerosis Complex-2 Human Renal Angiomyolipoma: Epidermal Growth Factor Is the Required Growth Factor Am. J. Pathol., October 1, 2005; 167(4): 1093 - 1103. [Abstract] [Full Text] [PDF]

				C. Wilson, S. Idziaszczyk, L. Parry, C. Guy, D. F.R. Griffiths, E. Lazda, R. A.L. Bayne, A. J.H. Smith, J. R. Sampson, and J. P. Cheadle A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma Hum. Mol. Genet., July 1, 2005; 14(13): 1839 - 1850. [Abstract] [Full Text] [PDF]

				J. A. Sosman Targeting of the VHL-Hypoxia-Inducible Factor-Hypoxia-Induced Gene Pathway for Renal Cell Carcinoma Therapy J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2695 - 2702. [Abstract] [Full Text] [PDF]

				P. L. Choyke, G. M. Glenn, M. M. Walther, B. Zbar, and W. M. Linehan Hereditary Renal Cancers Radiology, January 1, 2003; 226(1): 33 - 46. [Abstract] [Full Text] [PDF]

				M. Y. Liu, S. Cai, A. Espejo, M. T. Bedford, and C. L. Walker 14-3-3 Interacts with the Tumor Suppressor Tuberin at Akt Phosphorylation Site(s) Cancer Res., November 15, 2002; 62(22): 6475 - 6480. [Abstract] [Full Text] [PDF]

				K. S. Mcdorman and D. C. Wolf Use of the Spontaneous Tsc2 Knockout (Eker) Rat Model of Hereditary Renal Cell Carcinoma for the Study of Renal Carcinogens Toxicol Pathol, October 1, 2002; 30(6): 675 - 680. [Abstract] [PDF]

				P. Argani, A. Hawkins, C. A. Griffin, J. D. Goldstein, M. Haas, J. B. Beckwith, C. B. Mankinen, and E. J. Perlman A Distinctive Pediatric Renal Neoplasm Characterized by Epithelioid Morphology, Basement Membrane Production, Focal HMB45 Immunoreactivity, and t(6;11)(p21.1;q12) Chromosome Translocation Am. J. Pathol., June 1, 2001; 158(6): 2089 - 2096. [Abstract] [Full Text] [PDF]

				L. Khare, G. D Strizheva, J. N Bailey, K.-S. Au, H. Northrup, M. Smith, S. L Smalley, and E. P. Henske A novel missense mutation in the GTPase activating protein homology region of TSC2 in two large families with tuberous sclerosis complex J. Med. Genet., May 1, 2001; 38(5): 347 - 349. [Full Text]

				D.C. Wolf, T.L. Goldsworthy, D.B. Janszen, R. Harden, E.M. Donner, C.S. David, and J.I. Everitt Promotion by sodium barbital induces early development but does not increase the multiplicity of hereditary renal tumors in Eker rats Carcinogenesis, August 1, 2000; 21(8): 1553 - 1558. [Abstract] [Full Text] [PDF]

				G. Rennebeck, E. V. Kleymenova, R. Anderson, R. S. Yeung, K. Artzt, and C. L. Walker Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development PNAS, December 22, 1998; 95(26): 15629 - 15634. [Abstract] [Full Text] [PDF]